IRIS
SOLLA, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.411
AS - Asia 4.119
SA - Sud America 2.933
EU - Europa 1.472
Continente sconosciuto - Info sul continente non disponibili 235
AF - Africa 196
OC - Oceania 9
Totale 16.375
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.212
BR - Brasile 2.560
SG - Singapore 1.894
CN - Cina 664
VN - Vietnam 545
IT - Italia 381
HK - Hong Kong 378
FR - Francia 227
DE - Germania 213
AR - Argentina 144
UA - Ucraina 125
FI - Finlandia 104
GB - Regno Unito 97
CA - Canada 86
BD - Bangladesh 75
IN - India 74
RU - Federazione Russa 73
MX - Messico 65
TR - Turchia 64
ZA - Sudafrica 60
EC - Ecuador 59
IQ - Iraq 56
ID - Indonesia 50
VE - Venezuela 45
UZ - Uzbekistan 43
MA - Marocco 41
PK - Pakistan 36
CO - Colombia 34
NL - Olanda 33
JP - Giappone 31
ES - Italia 30
PL - Polonia 28
PY - Paraguay 26
TN - Tunisia 25
AE - Emirati Arabi Uniti 23
AT - Austria 23
PE - Perù 23
KE - Kenya 21
SE - Svezia 20
MY - Malesia 19
AZ - Azerbaigian 18
CZ - Repubblica Ceca 18
JO - Giordania 17
EG - Egitto 16
NP - Nepal 16
TH - Thailandia 16
PH - Filippine 15
UY - Uruguay 15
BE - Belgio 14
CL - Cile 14
CR - Costa Rica 14
LT - Lituania 13
JM - Giamaica 12
DZ - Algeria 11
BO - Bolivia 10
AU - Australia 9
EU - Europa 9
OM - Oman 9
IE - Irlanda 8
RS - Serbia 8
SA - Arabia Saudita 8
GR - Grecia 7
KG - Kirghizistan 7
LB - Libano 7
AL - Albania 6
BY - Bielorussia 6
DK - Danimarca 6
HN - Honduras 6
IL - Israele 6
KR - Corea 6
PS - Palestinian Territory 6
KZ - Kazakistan 5
RO - Romania 5
SN - Senegal 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BN - Brunei Darussalam 4
DO - Repubblica Dominicana 4
GE - Georgia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PA - Panama 3
BB - Barbados 2
EE - Estonia 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ME - Montenegro 2
MN - Mongolia 2
NG - Nigeria 2
QA - Qatar 2
SY - Repubblica araba siriana 2
Totale 16.127
Salva come PNG Salva come JPEG
Città #
Dallas 3.075
Singapore 946
San Jose 577
Chandler 513
Ashburn 386
Hong Kong 372
Santa Clara 281
Council Bluffs 225
Princeton 222
Columbus 207
Beijing 198
Ho Chi Minh City 189
Lauterbourg 161
São Paulo 159
Hanoi 126
Shanghai 109
Los Angeles 96
New York 84
Rio de Janeiro 83
Helsinki 81
Belo Horizonte 73
Munich 55
Brasília 53
Wilmington 46
Jacksonville 41
Rome 40
Frankfurt am Main 39
Johannesburg 39
Tashkent 39
Porto Alegre 36
The Dalles 36
Campinas 35
Orem 34
Cagliari 31
Brooklyn 30
Tokyo 29
Curitiba 27
Da Nang 27
Denver 27
Montreal 27
Jakarta 26
Quito 26
Toronto 26
Guarulhos 25
Haiphong 25
Mexico City 24
Nuremberg 24
Salvador 24
Atlanta 23
Baghdad 23
Buenos Aires 23
Chennai 22
Falls Church 22
Warsaw 21
London 20
Phoenix 19
Lima 18
Milan 18
San Francisco 18
Amman 17
Campo Grande 17
Düsseldorf 17
Houston 17
Juiz de Fora 17
Recife 17
Ribeirão Preto 17
Baku 16
Fortaleza 16
Franca 16
Nairobi 16
Poplar 16
Tianjin 16
Amsterdam 15
Bangkok 15
Contagem 15
Dhaka 15
Manaus 15
Turku 15
Asunción 14
Betim 14
Boston 14
Chicago 14
Florence 14
Guayaquil 14
Manchester 14
Santo André 14
Sassari 14
Sorocaba 14
Stockholm 14
Caracas 13
Falkenstein 13
Florianópolis 13
Guangzhou 13
Istanbul 13
Mauá 13
São José do Rio Preto 13
Tunis 13
Uberlândia 13
Brussels 12
Cape Town 12
Totale 9.881
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 347
Teaching Video NeuroImage: The "Chameleon Eyes Sign" in Myasthenia Gravis 211
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 197
Herv-k modulates the immune response in als patients 190
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 178
Diagnostic Value of the "Insular Knife-Cut" Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 169
The natural history of body-first versus brain-first Parkinson's disease subtypes 165
Adapted physical activity on motor and non-motor symptoms, and quality of life in Parkinson's disease patients 160
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 158
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 156
An Ancient Tradition, A New Kind Of Physical Activity: The Sardinian Folk Dance ‘Ballu Sardu’ 156
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 151
Early discontinuation and titration strategies in foslevodopa/foscarbidopa therapy for Parkinson's disease 150
Body weight-supported high-intensity locomotor training and adapted physical activity program in patients with Parkinson's disease: a complementary approach? 150
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 146
Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease 144
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI 144
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 143
Bipolar affective disorder and Parkinson's disease: A rare, insidious and often unrecognized association 141
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 140
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 139
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 139
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 139
Autoimmune encephalitis misdiagnosis and mimics 138
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 136
Alternating or metronome pisa syndrome in patients under drugs acting on dopaminergic pathways 136
C9ORF72 Intermediate Repeat Expansion in a Patient with Psychiatric Disorders and Progressive Cerebellar Ataxia 135
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 133
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment [2] 133
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: Drug effects of withania somnifera (Dunal) administration 130
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 130
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 127
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 120
Exposure to TNF inhibitors is rare at MOGAD presentation 117
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 115
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 114
VGF peptides as novel biomarkers in Parkinson’s disease 112
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia 112
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD 111
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 111
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 110
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 110
Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature 109
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 109
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease 107
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 106
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients 106
Land- and water-based sports activities in natural environments as a group exercise for Parkinson’s disease: proof-of-concept pilot study 105
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment? 104
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 104
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 103
Pisa-like syndrome under Baclofen in a patient with spastic hemiparesis due to ischemic stroke 103
Neurological and Psychiatric Disorders in the COVID-19 Era 102
Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease 102
Pisa syndrome in a patient with pathologically confirmed Parkinson's disease 102
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 101
Seasonal variation in myasthenia gravis incidence 100
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 99
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 98
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells 98
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 98
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 98
A new national survey of centers for cognitive disorders and dementias in Italy 97
Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease 97
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review 96
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data 96
Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 96
Capgras syndrome in Parkinson’s disease: two new cases and literature review 95
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease 94
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 94
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations 93
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 93
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 93
Delusional jealousy in Parkinson's disease patients with and without dementia 93
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases 92
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with parkinson’s disease 92
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 92
Neuroimaging evaluations of olfactory, gustatory, and neurological deficits in patients with long-term sequelae of COVID-19 92
Neuropsychological tests at the Italian Centers for Cognitive Disorders and Dementias: results from a survey on 450 specialized services 91
Nordic Walking for the Management of People With Parkinson Disease: A Systematic Review 91
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease 91
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 90
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 90
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 89
Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination 89
Olfactory hallucinations in Parkinson's disease patients and the role of their evaluation in clinical practice 88
Nonconvulsive status epilepticus as onset of Creutzfeldt-Jakob disease 88
Internal carotid artery dissection causing ischemic stroke during pole sport practice 87
Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease 87
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 87
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 85
Dopamine agonist withdrawal syndrome in Parkinson's disease 85
Functional neurological disorders and Parkinson's disease – A new research agenda? 84
Risk factors of Parkinson disease Simultaneous assessment, interactions, and etiologic subtypes 84
Treatment of benign essential blepharospasm with finasteride: A case report 83
Relationship between risk and protective factors and clinical features of Parkinson's disease 83
Neurological Consequences of COVID-19: A Systematic Review of the Pandemic’s Impact on Neurology Training 82
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson’s disease 82
Impact of supporting people with advanced Parkinson’s disease on carer’s quality of life and burden 82
Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study 82
Totale 11.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.732
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.732
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 0 0 0 10 11 14 6 27 18 22 99 211
2022/20231.000 120 74 58 149 76 173 3 99 171 13 40 24
2023/2024335 55 28 7 6 47 5 6 38 4 3 40 96
2024/20254.727 76 59 279 99 155 137 227 985 1.726 668 186 130
2025/20268.641 250 1.728 2.012 1.438 883 386 804 236 330 314 185 75
2026/2027977 137 596 244 0 0 0 0 0 0 0 0 0
Totale 16.375